2005
DOI: 10.1016/j.ohc.2005.05.001
|View full text |Cite
|
Sign up to set email alerts
|

Medical Therapy of Glaucoma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2006
2006
2016
2016

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(2 citation statements)
references
References 78 publications
0
2
0
Order By: Relevance
“…Despite this, IOPR is the mainstay of treatment. 2 Several studies have shown this to reduce the progression of optic nerve damage and visual field loss in patients with increased IOP [28][29][30] or NTG. 31…”
Section: Importance Of Iop In Glaucomamentioning
confidence: 99%
See 1 more Smart Citation
“…Despite this, IOPR is the mainstay of treatment. 2 Several studies have shown this to reduce the progression of optic nerve damage and visual field loss in patients with increased IOP [28][29][30] or NTG. 31…”
Section: Importance Of Iop In Glaucomamentioning
confidence: 99%
“…1 Despite advances in laser and surgical treatments, lowering of intraocular pressure (IOP) with topical drugs remains the initial treatment of choice for most patients. 2 The prostaglandin analogues and a 2 -agonists are two common classes of topical antiglaucomatous treatments that are being increasingly prescribed. 3 Latanoprost (Xalatan; Pharmacia, Peapack, New Jersey, USA) is a prodrug of a prostaglandin F 2a analogue that increases aqueous outflow predominantly through the uveoscleral pathway.…”
mentioning
confidence: 99%